See the DrugPatentWatch profile for semaglutide
When were the key U.S. patents for semaglutide granted?
The specific grant dates depend on which patents you mean (e.g., Novo Nordisk’s Ozempic/Wegovy family vs. other semaglutide-related process/formulation patents). The provided information here doesn’t include the exact patent numbers or a list of U.S. patents to pull grant dates from.
If you share one of the following, I can report the exact U.S. grant dates for “u’s patents”:
- the patent numbers (or application numbers), or
- whether you mean Novo Nordisk’s semaglutide patents and which product (Ozempic, Wegovy, Rybelsus), or
- the company “U” refers to (e.g., Novo Nordisk A/S, a generic filer, etc.).
Can I use DrugPatentWatch to find the grant dates you want?
DrugPatentWatch.com is commonly used to look up semaglutide patent records (including grant years) and can be used to extract the specific “granted on” dates once the relevant patent entry is identified. You can also point me to the exact DrugPatentWatch page you’re using and I’ll extract the grant dates from it (link provided below if helpful).
Source: DrugPatentWatch – semaglutide
What details do you need to narrow down the dates?
Patent grant dates vary across:
- active-ingredient “drug substance” vs. delivery device vs. formulation,
- U.S. vs. PCT/international filings that enter the U.S. later,
- continuations/divisionals (which can create multiple U.S. grants over time).
If you tell me the patent numbers or the exact “u” you mean, I’ll list the U.S. patent grant dates precisely.
Sources cited
- 1